ÌÇÐÄÆÆ½â°æ

Pharmaceutical industry in the United States

Statistics report about the pharmaceutical industry in the U.S.

This report presents graphs and tables about the pharmaceutical industry in the United States. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This report includes some of the most important key figures on the U.S. position in the world, top companies and products, medicine use facts, research and development, spending and payer distribution, and an outlook for the coming years.

Table of contents

Overview and positioning

5
  • Premium Statistic World pharmaceutical market distribution by submarket 2014-2025
  • Premium Statistic U.S. net medicine spending 2015-2030
  • Basic Statistic Market share of the leading global pharmaceutical markets 2024
  • Premium Statistic Top global pharmaceutical markets: growth rate 2024
  • Premium Statistic U.S. biopharmaceutical export volume 2002-2025

Competitive landscape

6
  • Premium Statistic Leading U.S. biotech and pharmaceutical companies 2026, by revenue
  • Premium Statistic Johnson & Johnson revenue 2005-2025
  • Premium Statistic Eli Lilly's total revenue 2007-2025
  • Premium Statistic Merck & Co. revenue 2006-2025
  • Premium Statistic Pfizer revenue 2006-2025
  • Basic Statistic AbbVie revenue 2010-2025

Segments and products

6
  • Premium Statistic Leading therapy areas by pharma revenue in the U.S. 2025
  • Premium Statistic Top pharma products by prescriptions U.S. 2023
  • Premium Statistic U.S. leading prescribed drugs based on sales 2025
  • Premium Statistic Pharmaceutical corporations by U.S. revenue 2025
  • Premium Statistic OTC total sales volume in the U.S. 2017-2025
  • Premium Statistic OTC pharmaceutical market revenue 2026, by segment

R&D and innovation

6
  • Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2024
  • Premium Statistic U.S. pharma industry R&D spending as a percent of total revenue 1990-2024
  • Premium Statistic Research & development spending on drug development in the U.S. 2024
  • Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
  • Premium Statistic Number of novel drugs approved annually by CDER 2008-2025
  • Premium Statistic Number of orphan designations accepted in the U.S. 2003-2025

Spending and payer mix

6
  • Basic Statistic Prescription drug expenditure in the U.S. 1960-2024
  • Basic Statistic Prescription drugs spending in the U.S. by payer 2010-2024
  • Premium Statistic Savings through generic drug usage in the U.S. 2008-2024
  • Premium Statistic U.S. brand and generic prescription drug spending 2020-2023
  • Premium Statistic Per capita prescribed medicines spending in high-income countries 2022
  • Premium Statistic Prescription drug market revenue distribution in the U.S. and the OECD 2022

Outlook

4
  • Premium Statistic Pharma market growth rate in the United States 2017-2030
  • Premium Statistic Major drugs losing patent protection worldwide 2025-2030
  • Premium Statistic Price reduction of major Medicare expenditure drugs U.S. 2026
  • Premium Statistic Estimated average growth of major pharmaceutical companies 2026-2030
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.